TORNTPHARM IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| METRIC | FY | LOW | AVG | HIGH | ACTUAL |
|---|---|---|---|---|---|
| EPS | FY27 | 57 | 64 | 75 | — |
| NET_PROFIT | FY27 | 2,167 | 2,402 | 2,709 | — |
| REVENUE | FY27 | 19,469 | 19,965 | 20,783 | — |
| EPS | FY28 | 77 | 91 | 104 | — |
| NET_PROFIT | FY28 | 2,912 | 3,408 | 3,940 | — |
| REVENUE | FY28 | 20,783 | 22,438 | 23,673 | — |
| QTR | METRIC | ACTUAL | EST | SURPRISE |
|---|---|---|---|---|
| Q2 FY27 | EPS | 14 | — | — |
| Q2 FY27 | REVENUE | 4,979 | — | — |
| Q2 FY27 | NETPROFIT | 541 | — | — |
| Q1 FY27 | EPS | 15 | — | — |
| Q1 FY27 | REVENUE | 4,921 | — | — |
| Q1 FY27 | NETPROFIT | 582 | — | — |
| Q4 FY26 |
| EPS |
| 13 |
| — |
| — |
| Q4 FY26 | REVENUE | 4,197 | — | — |
| Q4 FY26 | NETPROFIT | 434 | — | — |
| Q3 FY26 | EPS | 19 | — | — |
| Q3 FY26 | REVENUE | 3,303 | — | — |
| Q3 FY26 | NETPROFIT | 643 | — | — |